Yu Kang | Obstetrics and Gynecology | Best Researcher Award

Published on by China Scientist

Prof .Yu Kang | Obstetrics and Gynecology | Best Researcher Award

Innovative Research Projects:
  • Dr. Kang has successfully led and participated in 16 research projects, including collaborations with prestigious institutions like MD Anderson, underscoring his role in advancing cancer treatment methodologies.
Prof. Yu Kang , Obstetrics & Gynecology Hospital of Fudan University, China

Profile

Scopus

🌱EARLY ACADEMIC PURSUITS

  • Dr. Yu Kang obtained his PhD and completed his postdoctoral fellowship at MD Anderson Cancer Research Center, which laid a strong foundation for his research in gynecologic oncology. His early education focused on the mechanisms of cancer biology and treatment modalities, establishing a profound understanding of the complexities of gynecologic tumors.

💼 PROFESSIONAL ENDEAVORS

  • Currently serving as the chief physician at the Obstetrics & Gynecology Hospital of Fudan University, Dr. Kang is also a doctoral supervisor. His clinical practice centers around individualized precision treatment and prevention strategies for gynecologic tumors, ensuring that patients receive the most effective therapies tailored to their specific needs.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Kang’s main research focus includes ovarian cancer, PJ syndrome, and hereditary breast and ovarian cancer (HBOC). He has published extensively in prestigious journals such as JNCI, contributing significantly to the understanding and treatment of rare gynecological tumors. His research has led to the publication of 32 SCI articles, the acquisition of 4 national patents, and the authorship of 12 monographs.

📚 ACADEMIC CITES 

  • While specific citation metrics are not provided, Dr. Kang’s prolific output of 53 journal publications in SCI and Scopus-indexed journals underscores his impact in the academic community and highlights the significance of his research findings in advancing gynecologic cancer treatment.

🌍 Impact and Influence

  • Through his research and clinical practice, Dr. Kang has made significant strides in the field of gynecologic oncology, particularly in precision medicine. His collaborative efforts with organizations such as the MD Anderson Cancer Center Sister Organization Network Foundation have further advanced the potential treatment options for epithelial ovarian cancer, showcasing his commitment to improving patient outcomes.

🌟 Legacy and Future Contributions

  • Dr. Kang’s ongoing work in the field of gynecologic tumors aims to pave the way for innovative treatment modalities and improved patient care. With several patents in process and an active editorial role in Gynecologic Oncology, he is poised to continue influencing the field significantly. His commitment to research and patient care ensures a lasting legacy in gynecologic oncology.

📄Publications

  • MRI grading for informed clinical decision-making in Peutz–Jeghers syndrome patients with cervical lesions
    Authors: Jiang, A., Chen, Y., Ning, Y., Xu, C., Kang, Y.
    Journal: Scientific Reports, 2024, 14(1), 23731
  • Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis
    Authors: Zheng, K., Gao, Y., Xu, C., Kang, Y.
    Journal: Journal of Gynecologic Oncology, 2024, 35(4), e96
  • Immunotherapy combined with targeted therapy in advanced small cell carcinoma of the ovary of hypercalcemic type: A case of overall survival lasting for over 5 years
    Authors: Gao, Y., Zang, L., Ye, Y., Wang, H., Xu, C., Kang, Y.
    Journal: European Journal of Obstetrics and Gynecology and Reproductive Biology, 2024, 297, pp. 270–274
  • Correction to: Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer
    Authors: Li, K., Xu, J., Wang, J., Wu, S., Kang, Y.
    Journal: Cancer Immunology, Immunotherapy, 2024, 73(6), 105
  • Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study
    Authors: Wang, J., Du, Y., Kang, Y.
    Journal: International Journal of Gynecology and Obstetrics, 2024, 165(3), pp. 1229–1236

Prof. Cuifang Hao | Reproduction | Best Researcher Award | 1162

Published on by China Scientist

 

Prof. Cuifang Hao | Reproduction | Best Researcher Award

Prof. Cuifang Hao,Qingdao Woman and Children’s Hospital , China

 Profile

Scopus

Google Scholar

📚 Early Academic Pursuits

Cuifang Hao embarked on her academic journey with a passion for reproductive medicine. She honed her expertise in the diagnosis and treatment of female infertility, focusing on conditions like ovulation disorders, polycystic ovary syndrome (PCOS), ovarian dysfunction, repeated implantation failures, and thin endometrium. Her early academic achievements laid a strong foundation for her future contributions to the field.

💼 Professional Endeavors

As an archiater at the Centre for Reproductive Medicine, Women and Children’s Hospital, Qingdao University, Cuifang Hao has made significant strides in her career. She serves as a doctoral supervisor and has been recognized as a national excellent science and technology worker. Additionally, she is an outstanding contribution expert of the National Health and Family Planning Commission and an outstanding middle-age and young expert of Shandong Province. Her work primarily revolves around the application of assisted reproductive technology.

🔬CONTRIBUTIONS AND RESEARCH FOCUS

  • Cuifang Hao’s research has led to groundbreaking findings in reproductive medicine. She has hosted two National Natural Science Foundation projects and four provincial and municipal research projects. Notable among her contributions is the “high estrogen” theory of ovulation disorder and the innovative “core-pulling” resection of hydrosalpinx. Her research aims to improve the understanding and treatment of female infertility, with a particular focus on PCOS and other ovulation-related disorders.

🌟Impact and Influence

  • Cuifang Hao has made a significant impact through her research and clinical work. She has won numerous awards, including two third prizes in National Maternal and Child Health Science and Technology, one second prize and one third prize in Shandong Province Science and Technology Achievements, one second prize and one third prize in Shandong Medical Science and Technology, and three second prizes in Yantai City Science and Technology Achievements. Her contributions have been instrumental in advancing reproductive health care in China.

 📖 ACADEMIC CITES

Cuifang Hao’s work is widely recognized and cited in the academic community. She has published over 126 papers as the first author and corresponding author, with 37 of these papers being published in SCI-indexed journals.

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Cuifang Hao’s legacy in the field of reproductive medicine is marked by her innovative research and dedicated clinical practice. As a member of the Reproductive Committee of the Chinese Medical Association and vice chairman of several provincial committees, she continues to influence reproductive health policies and practices. Her future contributions are anticipated to further advance the understanding and treatment of female infertility, solidifying her legacy as a pioneer in reproductive medicine.

📰PUBLICATIONS

    • 1. Prediction Model for Missed Abortion of Patients Treated with IVF-ET Based on XGBoost: A Retrospective Study

      • Authors: Yuan, G., Lv, B., Du, X., Liu, Y., Hao, C.
      • Journal: PeerJ

      2. Application of Artificial Neural Networks in Reproductive Medicine

      • Authors: Yuan, G., Lv, B., Hao, C.
      • Journal: Human Fertility

      3. Intrauterine Perfusion of Autologous Platelet-Rich Plasma Before Frozen-Thawed Embryo Transfer Improves the Clinical Pregnancy Rate of Women With Recurrent Implantation Failure

      • Authors: Xu, Y., Hao, C., Fang, J., Xue, P., Miao, R.
      • Journal: Frontiers in Medicine

      4. Live Birth with or Without Preimplantation Genetic Testing for Aneuploidy

      • Authors: Yan, J., Qin, Y., Zhao, H., Legro, R.S., Chen, Z.-J.
      • Journal: New England Journal of Medicine

      5. Effect of Orlistat on Live Birth Rate in Overweight or Obese Women Undergoing IVF-ET: A Randomized Clinical Trial

      • Authors: Wang, Z., Zhao, J., Ma, X., Tan, J., Shi, Y.
      • Journal: Journal of Clinical Endocrinology and Metabolism